Guizhou Yibai Pharmaceutical Co Ltd (600594) — Capital Reinvestment Ratio
Guizhou Yibai Pharmaceutical Co Ltd (600594) has a Capital Reinvestment Ratio of 0.21x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥33.28 Million) in capital expenditures (CN¥7.08 Million). See 600594 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guizhou Yibai Pharmaceutical Co Ltd Capital Reinvestment Ratio (2002–2025)
This chart tracks Guizhou Yibai Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 23 annual periods. Check Guizhou Yibai Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Guizhou Yibai Pharmaceutical Co Ltd (2002–2025)
Year-by-year Capital Reinvestment Ratio for Guizhou Yibai Pharmaceutical Co Ltd from 2002 to 2025. For live market cap and broader valuation context, see 600594 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | CN¥256.71 Million | CN¥34.99 Million | ▼ -87.7% |
| 2024 | 1.11x | CN¥86.87 Million | CN¥96.32 Million | ▲ +221.1% |
| 2023 | 0.35x | CN¥377.61 Million | CN¥130.38 Million | ▼ -63.1% |
| 2022 | 0.94x | CN¥345.30 Million | CN¥322.92 Million | ▲ +95.1% |
| 2021 | 0.48x | CN¥934.21 Million | CN¥447.78 Million | ▼ -55.6% |
| 2020 | 1.08x | CN¥366.66 Million | CN¥395.74 Million | ▲ +94.5% |
| 2019 | 0.55x | CN¥362.71 Million | CN¥201.28 Million | ▼ -63.0% |
| 2018 | 1.50x | CN¥214.30 Million | CN¥321.33 Million | ▲ +153.8% |
| 2017 | 0.59x | CN¥681.78 Million | CN¥402.80 Million | ▼ -32.4% |
| 2016 | 0.87x | CN¥380.62 Million | CN¥332.53 Million | ▲ +74.0% |
| 2015 | 0.50x | CN¥573.68 Million | CN¥288.02 Million | ▲ +33.3% |
| 2014 | 0.38x | CN¥541.58 Million | CN¥203.94 Million | ▼ -20.5% |
| 2013 | 0.47x | CN¥577.24 Million | CN¥273.48 Million | ▼ -34.9% |
| 2012 | 0.73x | CN¥288.01 Million | CN¥209.64 Million | ▲ +42.1% |
| 2011 | 0.51x | CN¥277.83 Million | CN¥142.34 Million | ▲ +19.3% |
| 2010 | 0.43x | CN¥115.66 Million | CN¥49.66 Million | ▼ -0.1% |
| 2009 | 0.43x | CN¥103.88 Million | CN¥44.62 Million | ▲ +29.3% |
| 2008 | 0.33x | CN¥189.26 Million | CN¥62.86 Million | ▼ -89.8% |
| 2007 | 3.26x | CN¥11.94 Million | CN¥38.97 Million | ▲ +1738.0% |
| 2006 | 0.18x | CN¥95.77 Million | CN¥17.00 Million | ▼ -96.2% |
| 2005 | 4.66x | CN¥17.38 Million | CN¥80.99 Million | ▲ +153.2% |
| 2003 | 1.84x | CN¥92.10 Million | CN¥169.47 Million | ▲ +501.0% |
| 2002 | 0.31x | CN¥73.46 Million | CN¥22.49 Million | — |